Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 1 records, 1 pages
Search For: CAR T-Cell Therapy for Multiple Myeloma
Global CAR T-Cell Therapy for Multiple Myeloma Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Medical Care
CAR T-Cell Therapy for Multiple Myeloma
According to our (Global Info Research) latest study, the global CAR T-Cell Therapy for Multiple Myeloma market size was valued at USD 168.7 million in 2023 and is forecast to a readjusted size of USD 982.2 million by 2030 with a CAGR of 28.6% during review period.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: CAR T-Cell Therapy for Multiple Myeloma
Total: 1 records, 1 pages
According to our (Global Info Research) latest study, the global CAR T-Cell Therapy for Multiple Myeloma market size was valued at USD 168.7 million in 2023 and is forecast to a readjusted size of USD 982.2 million by 2030 with a CAGR of 28.6% during review period.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>